Behcet's syndrome: one year in review 2022


Creative Commons License

Hatemi G., SEYAHİ E., Fresko I., Talarico R., Ucar D., Hamuryudan V.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.40, no.8, pp.1461-1471, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 40 Issue: 8
  • Publication Date: 2022
  • Doi Number: 10.55563/clinexprheumatol/h4dkrs
  • Journal Name: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, Veterinary Science Database
  • Page Numbers: pp.1461-1471
  • Keywords: Behcet's syndrome, epidemiology, pathogenesis, genetics, outcome measures, clinical findings, management, WALL THICKNESS, DISEASE, MULTICENTER, APREMILAST, DIAGNOSIS, FEATURES, UVEITIS, SINGLE, ULCERS
  • Istanbul University Affiliated: Yes

Abstract

This review highlights publications on different aspects of Behcet's syndrome (BS) that appeared in 2021 and pro-vides a critical view. These publications include works on the epidemiology of BS across different continents, newly developed instruments to assess damage in BS, studies highlighting the immunopathogenesis, genetics and epigenetic factors, histopathology of the pathergy lesion, clinical and imaging aspects of vascular involvement, and safety and efficacy of therapeutic agents including tocilizumab, apremi-last and direct oral anticoagulants.